BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Daxor Corporation (DXR) Announces Placement of BVA-100 Blood Volume Analyzer at Austin Nuclear Pharmacy, Inc.


5/17/2013 10:55:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, NY--(Marketwired - May 16, 2013) -

Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced today that Austin Nuclear Pharmacy, Inc. has leased a BVA-100 Blood Volume Analyzer.

Austin Nuclear Pharmacy, Inc., established in 2002, is an independently owned and operated nuclear pharmacy which specializes in providing products and services to many outpatient diagnostic imaging centers and hospitals with nuclear medicine imaging capabilities. Along with its two sister pharmacies located in Temple, TX and San Antonio, Texas, these services can now be provided to a large geographic region.

Blood Volume analysis is not new in patient management. The technology has been available for years. The previous method was very cumbersome, expensive, and not always reliable. Blood volume analysis is essential in maintaining an accurate balance of fluids (blood) in critically ill patients. Multiple independent research papers have been published verifying outcomes where blood volume measurement, utilizing the BVA-100, is utilized to guide therapy.

Tom Wilkinson, President of Austin Nuclear Pharmacy Inc. stated, "In collaboration with physicians, we strive to provide the most effective tools available to diagnose and manage patients with many complicated diseases. Daxor BVA testing is an exceptionally valuable asset that will assist in reducing cost, provide accurate diagnosis and, in the long term, efficient patient outcomes. Daxor and Austin Nuclear Pharmacy Inc. partnering will provide the ability to provide critical information to enhance patient care and outcomes. Austin Nuclear Pharmacy Inc. is committed to our clients and ultimately to the patients in the community. We are extremely excited to bring this valued tool to Austin and the surrounding areas."

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.


Daxor Contact Information:
Richard Dunn
Director of Operations
212-330-8502
rdunn@daxor.com
or
Diane Meegan
Investor Relations
dmeegan@daxor.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES